| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,040,000 |
| Market
Cap: |
1.03(B) |
| Last
Volume: |
76,253 |
Avg
Vol: |
95,296 |
| 52
Week Range: |
$41.52 - $67.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ INDUSTRIAL |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile USANA Health Sciences develops and manufactures science-based nutritional, personal care and skincare products. Co.'s principal product lines include: USANA® Nutritionals Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs; Essentials/CellSentials®, which includes primary vitamin and mineral supplements that provide a foundation of body nutrition for every age group with children 13 months of age; Foods, which includes meal replacement shakes, snack bars, and other related products that provide macro-nutrition in various formats; and Personal Care and Skincare, which includes its science-based personal care products and Celavive.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
36,990 |
48,445 |
65,028 |
143,144 |
| Total Sell Value |
$1,763,385 |
$2,312,477 |
$3,371,359 |
$8,352,397 |
| Total People Sold |
9 |
12 |
14 |
16 |
| Total Sell Transactions |
10 |
15 |
26 |
50 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jones Paul A. |
Chief Leadership Dev Officer |
• – – |
2020-10-23 |
4 |
D |
$85.86 |
$15,283 |
D/D |
(178) |
5,406 |
|
- |
|
| Jones Paul A. |
Chief Leadership Dev Officer |
• – – |
2020-10-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
550 |
5,584 |
|
- |
|
| Noot Walter |
Chief Operating Officer |
• – – |
2020-10-23 |
4 |
D |
$85.86 |
$24,041 |
D/D |
(280) |
351 |
|
- |
|
| Noot Walter |
Chief Operating Officer |
• – – |
2020-10-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
631 |
631 |
|
- |
|
| Iiekking G Doug |
CFO |
• – – |
2020-10-23 |
4 |
D |
$85.86 |
$18,717 |
D/D |
(218) |
2,367 |
|
- |
|
| Iiekking G Doug |
CFO |
• – – |
2020-10-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
672 |
2,585 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2020-10-23 |
4 |
D |
$85.86 |
$22,238 |
D/D |
(259) |
318 |
|
- |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2020-10-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
577 |
577 |
|
- |
|
| Auciaux Robert |
Director |
– • – |
2020-10-23 |
4 |
S |
$85.29 |
$84,352 |
D/D |
(989) |
426 |
|
-18% |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2020-10-22 |
4 |
S |
$82.00 |
$495,526 |
D/D |
(6,043) |
0 |
|
-19% |
|
| Sinnott Robert A |
Chief Scientific Officer |
• – – |
2020-10-22 |
4 |
OE |
$65.48 |
$395,696 |
D/D |
6,043 |
6,043 |
|
- |
|
| Peng Feng |
Director |
– • – |
2020-10-22 |
4 |
S |
$82.81 |
$27,327 |
D/D |
(330) |
1,181 |
|
-19% |
|
| Wood Timothy E |
Director |
– • – |
2020-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
426 |
426 |
|
- |
|
| Pelosi Peggie |
Director |
– • – |
2020-10-21 |
4 |
D |
$85.39 |
$15,968 |
D/D |
(187) |
1,092 |
|
- |
|
| Pelosi Peggie |
Director |
– • – |
2020-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
426 |
1,518 |
|
- |
|
| Winssinger Frederic J |
Director |
– • – |
2020-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
426 |
1,352 |
|
- |
|
| Fuller Gilbert A |
Director |
– • – |
2020-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
426 |
426 |
|
- |
|
| Auciaux Robert |
Director |
– • – |
2020-10-21 |
4 |
D |
$81.50 |
$10,432 |
D/D |
(128) |
1,415 |
|
- |
|
| Auciaux Robert |
Director |
– • – |
2020-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
426 |
1,543 |
|
- |
|
| Peng Feng |
Director |
– • – |
2020-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
426 |
1,511 |
|
- |
|
| Gull Global Ltd |
10% Owner |
– – • |
2020-08-21 |
4 |
S |
$80.00 |
$48,000,000 |
I/I |
(600,000) |
8,485,743 |
|
-0% |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2020-08-20 |
4 |
S |
$83.15 |
$22,451 |
D/D |
(270) |
0 |
|
6% |
|
| Neidig Brent |
Chief Officer & MD of China |
• – – |
2020-08-13 |
4 |
S |
$83.76 |
$21,776 |
D/D |
(260) |
0 |
|
7% |
|
| Wood Timothy E |
Director |
– • – |
2020-07-29 |
4 |
S |
$81.35 |
$34,655 |
D/D |
(426) |
0 |
|
5% |
|
| Fuller Gilbert A |
Director |
– • – |
2020-07-29 |
4 |
S |
$81.00 |
$34,506 |
D/D |
(426) |
0 |
|
5% |
|
2039 Records found
|
|
Page 24 of 82 |
|
|
1.18 (2.48%) 
